Janney Montgomery Scott LLC Xeris Biopharma Holdings, Inc. Transaction History
Janney Montgomery Scott LLC
- $32.8 Billion
- Q2 2024
A detailed history of Janney Montgomery Scott LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 10,750 shares of XERS stock, worth $31,820. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,750
Previous 10,303
4.34%
Holding current value
$31,820
Previous $23,000
4.35%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding XERS
# of Institutions
133Shares Held
57MCall Options Held
126KPut Options Held
45K-
Black Rock Inc. New York, NY10.3MShares$30.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.66MShares$22.7 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$15.1 Million61.49% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.83MShares$14.3 Million1.75% of portfolio
-
State Street Corp Boston, MA3.26MShares$9.65 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $402M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...